Citation Impact
Citing Papers
HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help
2003 StandoutScienceNobel
Characterization of a canine homolog of hepatitis C virus
2011 StandoutNobel
Tough adhesives for diverse wet surfaces
2017 StandoutScience
Memory CD8 + T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection
2003 StandoutNobel
Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity
2004 StandoutNobel
Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study
1999
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018 Standout
Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part I: Technological concepts and evolution
2006 Standout
The Treatment of Chronic Viral Hepatitis
1997
Diagnosis, management, and treatment of hepatitis C†
2004
Hepatocellular carcinoma
2003 Standout
Hepatitis C: the clinical spectrum of the disease
1999
Hepatitis C Virus and eliminating post-transfusion hepatitis
2000 StandoutNobel
A Case-Control Study of Risk Factors for Sporadic Hepatitis C Virus Infection in The Southwestern United States
1999
Risk factors for hepatitis C virus infection in United States blood donors
2000
The Safety of Valproic Acid Use for Patients With Hepatitis C Infection
2002
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Hepatitis C Virus Infection
2001 Standout
Rising Incidence of Hepatocellular Carcinoma in the United States
1999 Standout
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 Standout
Prevalence and risk factors for hepatitis C virus infection at an Urban veterans administration medical center
2001
Nonalcoholic Fatty Liver Disease
2002 Standout
Course and outcome of hepatitis C
2002
Patient-to-Patient Transmission of Hepatitis C Virus during Colonoscopy
1997
Prevalence and Clinical Outcome of Hepatitis C Infection in Children Who Underwent Cardiac Surgery before the Implementation of Blood-Donor Screening
1999
Platelet gel: An autologous alternative to fibrin glue with applications in oral and maxillofacial surgery
1997
Changing epidemiologic pattern of chronic hepatitis C virus infection in Italian children
1998
The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae
2010
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
1999 Standout
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
2011 StandoutNobel
Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)
2009 Standout
Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo
2006 StandoutNobel
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection
2006 StandoutNobel
Interferon Alpha-2b and Ribavirin for Patients with Chronic Hepatitis C and Normal ALT
2004
Transfusion Medicine — Blood Transfusion
1999 Standout
Silencing of USP18 Potentiates the Antiviral Activity of Interferon Against Hepatitis C Virus Infection
2006 StandoutNobel
Testing of individual blood donations for HCV RNA reduces the residual risk of transfusion‐transmitted HCV infection
2000
Sustained virological response rates and health‐related quality of life after interferon and ribavirin therapy in patients with chronic hepatitis C virus infection and persistently normal alanine aminotransferase levels
2006
Hepatitis C: an update
2001
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Epidemiology of hepatitis C
1997 Standout
Purification of Salmon Clotting Factors and Their Use as Tissue Sealants
2000
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti‐HCV
2004
The potential impact of the preparation rich in growth factors (PRGF) in different medical fields
2007
Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels
1997
Determinants for Membrane Association of the Hepatitis C Virus RNA-dependent RNA Polymerase
2001 StandoutNobel
Clinical management of HCV carriers with normal aminotransferase levels
2003
Epidemiology of hepatitis C
1996
HCV transmission in industrialized countries and resource-constrained areas
2013
Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part V: Histologic evaluations of PRF effects on bone allograft maturation in sinus lift
2006
Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: A 20-year multicenter study
2000
Prevention of spread of hepatitis C
2002
Nonlinear elasticity in biological gels
2005 StandoutNature
THE EPIDEMIOLOGY OF ACUTE AND CHRONIC HEPATITIS C
1997
Management of hepatitis C
2003
Analysis of a Successful Immune Response against Hepatitis C Virus
1999 StandoutNobel
Hepatitis C: The clinical spectrum of disease
1997
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
Global control of hepatitis C: where challenge meets opportunity
2013
Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: A French survey of 6,664 patients
1997
Interferons α and λ Inhibit Hepatitis C Virus Replication With Distinct Signal Transduction and Gene Regulation Kinetics
2006 StandoutNobel
Recovery, Persistence, and Sequelae in Hepatitis C Virus Infection: A Perspective on Long-Term Outcome
2000
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Absence of hepatitis C virus transmission but frequent transmission of HIV-1 from sexual contact with doubly-infected individuals
1997
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Strategies and Prospects for Vaccination Against the Hepatitis C Viruses
2000 StandoutNobel
Hepatitis C virus carriers with persistently normal aminotransferase levels: healthy people or true patients?
2000
Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population
2006
The Risk of Hepatitis C Virus Infection Among Blood Donors in Osaka, Japan
1998
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
Hepatitis C virus infection in the United States
1999
A 24‐week course of high‐dose interferon‐α plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near‐normal alanine aminotransferase levels
2006
Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin
1999
Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production
2005 StandoutNobel
Hepatitis C
1998
Replication of hepatitis C virus
2007 StandoutNobel
Prospective Comparison of Whole-Blood- and Plasma-Based Hepatitis C Virus RNA Detection Systems: Improved Detection Using Whole Blood as the Source of Viral RNA
1999
The relationship between blood groups and disease
2010
Binding of Hepatitis C Virus to CD81
1998 StandoutScienceNobel
Intrahepatic Gene Expression during Chronic Hepatitis C Virus Infection in Chimpanzees
2004
Fibrin Sealant Adhesive Systems: A Review of Their Chemistry, Material Properties and Clinical Applications
1993
Characterization of nonprimate hepacivirus and construction of a functional molecular clone
2015 StandoutNobel
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
2006 Standout
Antiviral Effect and Virus-Host Interactions in Response to Alpha Interferon, Gamma Interferon, Poly(I)-Poly(C), Tumor Necrosis Factor Alpha, and Ribavirin in Hepatitis C Virus Subgenomic Replicons
2002
Course and outcome of hepatitis C
2002
Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels
2002
Viraemic frequencies and seroprevalence of non-primate hepacivirus and equine pegiviruses in horses and other mammalian species
2014
Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA
2005 StandoutScience
Cytotoxicity analyses of Choukroun’s platelet-rich fibrin (PRF) on a wide range of human cells: The answer to a commercial controversy
2007
Prevention of spread of hepatitis C
2002
The Use of Autologous Platelet-Rich Plasma (Platelet Gel) and Autologous Platelet-Poor Plasma (Fibrin Glue) in Cosmetic Surgery
2001
Preterm labor: One syndrome, many causes
2014 StandoutScience
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders
2005 StandoutNobel
Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients
2003 StandoutNobel
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
1998 StandoutScience
A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades
2002
Presence of functional dendritic cells in patients chronically infected with hepatitis C virus
2003 StandoutNobel
Structure of the catalytic domain of the hepatitis C virus NS2-3 protease
2006 StandoutNatureNobel
Works of Joan Gibble being referenced
Routes of Infection, Viremia, and Liver Disease in Blood Donors Found to Have Hepatitis C Virus Infection
1996
Analysis of Hepatitis G Virus (HGV) RNA, Antibody to HGV Envelope Protein, and Risk Factors for Blood Donors Coinfected with HGV and Hepatitis C Virus
1999
Fibrin glue: the perfect operative sealant?
1990
Radiofrequency identification technology can standardize and document blood collections and transfusions
2007